Pompano Seaside, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) — BioStem Applied sciences, Inc. (OTC PINK: BSEM) (“BioStem” or the “Firm”), a number one life sciences firm specializing in perinatal tissue allografts to be used in regenerative therapies, immediately introduced that it has filed its quarterly studies for 2020 to change into present with OTC Markets.
BioStem’s Chief Government Officer, Jason Matuszewski, commented, “The submitting of our 2020 quarterly studies not solely marks a key milestone for BioStem, but in addition displays the extent of transparency we try to realize for our shareholders. Present monetary reporting, together with elevated and well timed dialogue, are a prime precedence. We additionally proceed to take actions that target enhancing the lives of sufferers and their households, present enterprise resiliency, and restore the Firm’s monetary integrity and status. We really feel assured we are able to preserve present standing with our reporting necessities for OTC Markets with the addition of our key monetary group members; we’re transferring ahead!”
About BioStem Applied sciences, Inc. (OTC PINK: BSEM): BioStem Applied sciences, Inc. is a world life sciences company, offering progressive applied sciences with a focus in Regenerative Drugs. The corporate’s mission is to find, develop and produce the simplest Regenerative Drugs merchandise on the planet. BioStem Applied sciences gives a complete portfolio of high-quality manufacturers that embrace AEON™, RHEO™, OROPRO™, VENDAJE™, VENDAJE™ AC and VENDAJE™ OPTIC. The corporate is comprised of a various group of scientists, physicians, and entrepreneurs who collaborate to create progressive merchandise. These applied sciences enhance the High quality of Life for our sufferers and, in consequence, drive shareholder worth. For the most recent information and details about BioStem Applied sciences and its manufacturers, please go to www.biostemtechnologies.com
Ahead-Wanting Statements: Aside from historic truth statements, the issues mentioned on this press launch are forward-looking and made pursuant to the Protected Harbor provisions of the Non-public Securities Litigation Reform Act of 1995. “Ahead-looking statements” describe future expectations, plans, outcomes, or methods and are usually preceded by phrases resembling “future,” “plan” or “deliberate,” “expects,” consider” or “projected.” These forward-looking statements mirror quite a few assumptions and contain a wide range of dangers and uncertainties, lots of that are past the corporate’s management that will trigger precise outcomes to vary materially from said expectations. These danger components embrace, amongst others, restricted working historical past, problem in growing, exploiting and defending proprietary applied sciences, intense competitors, and extra dangers components as mentioned in studies filed by the corporate with OTC Markets.
BioStem Applied sciences, Inc.
Cellphone: 954-380-8342
Web site: http://www.biostemtechnologies.com
E mail: info@biostemtech.com
Twitter: @BSEM_Tech
Fb: https://www.facebook.com/biostemtechnologies/
Investor Relations:
info@biostemtech.com
(954) 380-8342
